IDEXX Laboratories Inc (IDXX) stock
IDXXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 17/3038% above fair value
$698.47+8.23 (+1.19%)
Close on Nov 18, 2026Market cap $55.03BP/E 49.1Yield –
IDEXX Laboratories market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
IDEXX Laboratories's market cap was $55.42B on Nov 11, 2026, against $60.23B a year earlier. Over the last 5 years it ranged from $27.18B to $60.23B, with a median of $41.45B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $55.42B | +2.4% |
| 2025 | Dec 31, 2025 | $54.12B | +59.6% |
| 2024 | Dec 31, 2024 | $33.92B | -26.4% |
| 2023 | Dec 29, 2023 | $46.11B | +36.2% |
| 2022 | Dec 30, 2022 | $33.86B | -39.4% |
| 2021 | Dec 31, 2021 | $55.89B | +31.1% |
| 2020 | Dec 31, 2020 | $42.64B | +90.1% |
| 2019 | Dec 31, 2019 | $22.43B | +39.3% |
| 2018 | Dec 31, 2018 | $16.10B | +14.5% |
| 2017 | Dec 29, 2017 | $14.07B | +31.6% |
| 2016 | Dec 30, 2016 | $10.69B | +60.7% |
| 2015 | Dec 31, 2015 | $6.65B | -13.5% |
| 2014 | Dec 31, 2014 | $7.68B | +32.0% |
| 2013 | Dec 31, 2013 | $5.82B | +11.2% |
| 2012 | Dec 31, 2012 | $5.24B | +15.8% |
| 2011 | Dec 30, 2011 | $4.52B | +9.1% |
| 2010 | Dec 31, 2010 | $4.14B | +24.6% |
| 2009 | Dec 31, 2009 | $3.33B | – |
See a number that looks wrong?